Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 151 entries
View as:

A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Participants With Early Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02956486 Org: User:
Start: 10/20/16 End: 01/15/20 Due: 01/15/21

A Study of Intravenous Perampanel in Japanese Participants With Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT03754582 Org: User:
Start: 11/27/18 End: 12/10/19 Due: 12/10/20

A Multiple Dose Pharmacokinetic Study of Perampanel in Korean Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02020486 Org: User:
Start: 12/31/13 End: 03/31/14 Due: 03/31/15

Exploring the Safety And Tolerability of Doses of E2007 up to a Maximum of 12 mg In Patients With Refractory Partial Seizures

Phase: N/A Priority: Normal
NCT ID: NCT00416195 Org: User:
Start: 12/31/06 End: 03/31/08 Due: 03/31/09

A Single and Multiple Dose Study of Lemborexant in Healthy Chinese Participants

Phase: N/A Priority: Normal
NCT ID: NCT04555733 Org: User:
Start: 10/26/20 End: 01/13/21 Due: 01/13/22

A Study of E2020 in Patients With Dementia With Lewy Bodies (DLB), Followed by a Long-term Extension Phase

Phase: N/A Priority: Normal
NCT ID: NCT01278407 Org: User:
Start: 02/28/11 End: 04/30/13 Due: 04/30/14

A Study of E6011 in Japanese Subjects With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT02196558 Org: User:
Start: 05/26/14 End: 07/13/17 Due: 07/13/18

A Bioequivalence Study of Film-coated Tablet and Dry Syrup 1% Form for E2020 in Healthy Japanese Adult Males

Phase: N/A Priority: Normal
NCT ID: NCT01506739 Org: User:
Start: 03/31/11 End: 05/31/11 Due: 05/31/12

E2022 Patch Formulation Single Dose Phase I Study

Phase: N/A Priority: Normal
NCT ID: NCT01253434 Org: User:
Start: 11/30/10 End: 03/31/11 Due: 03/31/12

A Study of E3810 for Japanese Subjects With Functional Dyspepsia (SAMURAI Study: Suppression of Acid Milieu With Rabeprazole Improving Functional Dyspepsia ) (Study E3810-J081-204)

Phase: N/A Priority: Normal
NCT ID: NCT01089543 Org: User:
Start: 04/30/10 End: 08/31/11 Due: 08/31/12

Post-marketing Surveillance of Lenvatinib Mesylate (Lenvima Capsule) in Patients With Unresectable Thyroid Cancer (Study LEN01T)

Phase: N/A Priority: Normal
NCT ID: NCT02430714 Org: User:
Start: 05/20/15 End: 11/06/16 Due: 11/06/17

Eribulin Versus Vinorelbine in Subjects With Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes

Phase: N/A Priority: Normal
NCT ID: NCT02225470 Org: User:
Start: 09/26/13 End: 06/22/18 Due: 06/22/19

A Study of E7090 as Monotherapy and in Combination With Other Anticancer Agents in Participants With Estrogen Receptor Positive (ER+) and Human Epidermal Growth Receptor 2 Negative (HER2-) Recurrent/Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04572295 Org: User:
Start: 10/09/20 End: 03/31/26 Due: 03/31/27

Study of E7389 for Advanced or Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00965523 Org: User:
Start: 01/31/08 End: 01/31/11 Due: 01/31/12

Pharmacokinetic Study of Perampanel in Chinese Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03424564 Org: User:
Start: 03/20/18 End: 05/25/18 Due: 05/25/19

Phase I Clinical Study of E7389

Phase: N/A Priority: Normal
NCT ID: NCT00326950 Org: User:
Start: 06/30/06 End: 02/29/08 Due: 02/28/09

Efficacy and Safety of Teprenone in Patients With Acute Gastritis, Acute Gastric Lesion of Chronic Gastritis With Acute Exacerbation or Gastric Ulcer

Phase: N/A Priority: Normal
NCT ID: NCT01190657 Org: User:
Start: 05/31/10 End: 02/28/13 Due: 02/28/14

Post-marketing Surveillance of Donepezil Hydrochloride - Investigation of Long Term Safety and Efficacy of Aricept as Well as Its Proper Use Information in Patients With Dementia With Lewy Bodies (DLB).

Phase: N/A Priority: Normal
NCT ID: NCT02448784 Org: User:
Start: 04/20/15 End: 03/30/17 Due: 03/30/18

A Phase II/III Study of SEP-190 (Eszopiclone) in Patients With Primary Insomnia (Study 190-126)

Phase: N/A Priority: Normal
NCT ID: NCT00770510 Org: User:
Start: 09/30/08 End: 05/31/10 Due: 05/31/11

A Comparative Study on the Efficacy and Safety of E3810 in Patients With Non-erosive Gastroesophageal Reflux Disease

Phase: N/A Priority: Normal
NCT ID: NCT00165646 Org: User:
Start: 09/30/04 End: 10/31/05 Due: 10/31/06

Long-term Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment (Planetarium Study)

Phase: N/A Priority: Normal
NCT ID: NCT01398410 Org: User:
Start: 12/31/11 End: 02/28/14 Due: 02/28/15

Phase 1b Trial of Lenvatinib Plus Pembrolizumab in Participants With Selected Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03006887 Org: User:
Start: 01/12/17 End: 04/15/20 Due: 04/15/21

A Long-Term Study in Patients With Amyotrophic Lateral Sclerosis (ALS)

Phase: N/A Priority: Normal
NCT ID: NCT00445172 Org: User:
Start: 02/29/08 End: 03/31/17 Due: 03/31/18

Study to Assess the Safety, Tolerability, and Pharmacokinetics of E2082 in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03402178 Org: User:
Start: 12/21/17 End: 02/20/20 Due: 02/20/21

A Study to Evaluate Efficacy of Dotinurad and Febuxostat for the Treatment of Participants With Gout

Phase: N/A Priority: Normal
NCT ID: NCT05007392 Org: User:
Start: 12/21/21 End: 06/14/23 Due: 06/14/24